XTLB - Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today's pre-market trading after the company announced results from its ongoing clinical trial of NX-5948 in patients with relapsed refractory chronic lymphocytic leukemia.
Nurix Therapeutics shares jumped 12.1% to $17.01 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) rose 89.4% to $6.61 in pre-market trading after surging 24% on Friday. Scinai Immunotherapeutics, last week, received a non-binding Letter of Intent from the European Investment Bank for converting loan into equity.
- Interactive Strength Inc. (NASDAQ:TRNR) shares rose 76.6% to $5.05 in pre-market trading after dipping 19% on Friday.
- ENDRA Life Sciences Inc. (NASDAQ:NDRA) gained 36.4% to $0.1414 in pre-market trading after a 13G filing showed a 9.99% passive stake from S.H.N. Financial Investments Ltd.
- The Aaron’s Company, Inc. (NYSE:AAN) gained 32.1% to $9.96 in pre-market trading after the company announced that it entered into a definitive agreement to be acquired by IQVentures Holdings.
- Venus Concept Inc. (NASDAQ: